---
schema_version: "secwatch.filing_event.v1"
accession: "0001121702-23-000073"
form_type: "8-K"
ticker: null
cik: "0001121702"
company_name: "YIELD10 BIOSCIENCE, INC."
filed_at: "2023-11-17T23:59:59+00:00"
generated_at: "2026-06-07T23:50:34.317419+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Yield10 receives Nasdaq delisting notice for failure to meet stockholders' equity extension terms

## Summary
- On Nov 15, 2023, Nasdaq notified Yield10 it did not meet terms of extension to comply with minimum $2.5M stockholders' equity requirement.
- Company failed to complete a planned $12M capital raise or finalize a definitive Camelina feedstock oil agreement with Marathon Petroleum.
- Outstanding $1M note from Marathon was not converted to common stock as part of the compliance plan.
- Yield10 also faces a separate Nasdaq deficiency for bid price below $1.00 per share since Sept 25, 2023.
- Company has appealed to the Nasdaq Hearings Panel, which stays any delisting action pending the hearing outcome.

## SEC filing metadata
- accession: 0001121702-23-000073
- form_type: 8-K
- cik: 0001121702
- company_name: YIELD10 BIOSCIENCE, INC.
- filed_at: 2023-11-17T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1121702/000112170223000073/0001121702-23-000073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1121702/000112170223000073/yten-20231115.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001121702-23-000073
- JSON: https://secwatch.observer/filing/0001121702-23-000073.json
- Plain text: https://secwatch.observer/filing/0001121702-23-000073.txt

## Key facts
- Listing & Compliance Notices
  YIELD10 BIOSCIENCE, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: September 25, 2023, the Company also received a deficiency letter from the Staff notifying the Company that it was not in compliance with the requirement to maintain a minimum bid price of at least $1.00 per share pursuant to Nasdaq Listing Rule 5550(a)(2). The Company is diligently working to regain compliance with all applicable Nasdaq listing criteria; however, there can be no assurance that a hearing with the Panel will be successful or, if the Panel determines to continue the Company’s listing, that the Company will be able to satisfy the continued listing criteria subsequent to the heari
  evidence_url: https://www.sec.gov/Archives/edgar/data/1121702/000112170223000073/0001121702-23-000073-index.htm
- Listing & Compliance Notices
  YIELD10 BIOSCIENCE, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: ng process has concluded. As previously disclosed, on September 25, 2023, the Company also received a deficiency letter from the Staff notifying the Company that it was not in compliance with the requirement to maintain a minimum bid price of at least $1.00 per share pursuant to Nasdaq Listing Rule 5550(a)(2). The Company is diligently working to regain compliance with all applicable Nasdaq listing criteria; however, there can be no assurance that a hearing with the Panel will be successful or, if the Panel determines to continue the Company’s listing, that the Company will be able to satisfy
  evidence_url: https://www.sec.gov/Archives/edgar/data/1121702/000112170223000073/0001121702-23-000073-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.